Literature DB >> 26233549

Protease-Activated Receptor-2 Up-Regulates Transient Receptor Potential Vanilloid 4 Function in Mouse Esophageal Keratinocyte.

Nobuhiro Suzuki1, Hiroshi Mihara2, Hirofumi Nishizono3, Makoto Tominaga4, Toshiro Sugiyama5.   

Abstract

BACKGROUND: The reflux of pancreatic-duodenal fluids is implicated in the pathophysiology of proton-pump inhibitor-resistant gastroesophageal reflux disease (GERD). Protease-activated receptor-2 (PAR-2) is activated by proteases, the pancreatic enzyme, trypsin, and the activated PAR-2 enhances transient receptor potential vanilloid 4 (TRPV4) function in neurons. TRPV4 stimulates ATP exocytosis in conjunction with the vesicular nucleotide transporter, which mediates mechano-transduction and vagal stimulation. The aim of the present study was to verify whether the activated PAR-2 up-regulates TRPV4 function in mouse esophageal keratinocytes, which may link to the pathophysiology in PPI-resistant GERD.
METHODS: TRPV4 and PAR-2 expressions were detected by RT-PCR, immunostaining, and western blotting in mouse esophageal keratinocytes. The functional response of TRPV4 to esophageal keratinocytes was analyzed using a Ca(2+) imaging system. Cellular ATP release was examined by luciferase-luciferin reaction. TRPV4 phosphorylation was studied by immunoprecipitation and western blotting.
RESULTS: PAR-2 and TRPV4 mRNAs and proteins were expressed in esophageal keratinocytes. Pre-treatment with trypsin significantly increased the responses to TRPV4 activator in esophageal keratinocytes, probably via the phosphorylation of serine residue of TRPV4 by protein kinase C and resulted in cellular ATP release from the cells.
CONCLUSIONS: Activated PAR-2 with trypsin exposure up-regulated TRPV4 function and increased ATP release in mouse esophageal keratinocytes. This mechanism might be related to the pathophysiology of GERD, especially non-erosive GERD.

Entities:  

Keywords:  ATP; GERD; Protease-activated receptor-2; Transient receptor potential vanilloid 4

Mesh:

Substances:

Year:  2015        PMID: 26233549     DOI: 10.1007/s10620-015-3822-6

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  38 in total

1.  Vagal afferent nerves with nociceptive properties in guinea-pig oesophagus.

Authors:  Shaoyong Yu; Bradley J Undem; Marian Kollarik
Journal:  J Physiol       Date:  2005-01-13       Impact factor: 5.182

2.  Non-erosive reflux disease (NERD)--acid reflux and symptom patterns.

Authors:  S D Martinez; I B Malagon; H S Garewal; H Cui; R Fass
Journal:  Aliment Pharmacol Ther       Date:  2003-02-15       Impact factor: 8.171

3.  Investigation of pretreatment prediction of proton pump inhibitor (PPI)-resistant patients with gastroesophageal reflux disease and the dose escalation challenge of PPIs-TORNADO study: a multicenter prospective study by the Acid-Related Symptom Research Group in Japan.

Authors:  Takahisa Furuta; Tomohiko Shimatani; Mitsushige Sugimoto; Shunji Ishihara; Yasuhiro Fujiwara; Motoyasu Kusano; Tomoyuki Koike; Michio Hongo; Tsutomu Chiba; Yoshikazu Kinoshita
Journal:  J Gastroenterol       Date:  2011-08-24       Impact factor: 7.527

4.  Multimodal pain stimulations in patients with grade B oesophagitis.

Authors:  A M Drewes; H Reddy; J Pedersen; P Funch-Jensen; H Gregersen; L Arendt-Nielsen
Journal:  Gut       Date:  2005-08-09       Impact factor: 23.059

5.  Antagonism of protease-activated receptor 2 protects against experimental colitis.

Authors:  Rink-Jan Lohman; Adam J Cotterell; Jacky Suen; Ligong Liu; Anh T Do; David A Vesey; David P Fairlie
Journal:  J Pharmacol Exp Ther       Date:  2011-10-25       Impact factor: 4.030

6.  Impaired osmotic sensation in mice lacking TRPV4.

Authors:  Atsuko Mizuno; Naoko Matsumoto; Masashi Imai; Makoto Suzuki
Journal:  Am J Physiol Cell Physiol       Date:  2003-07       Impact factor: 4.249

7.  Effect of age and correlation between esophageal visceral chemosensitivity and mechanosensitivity in healthy Japanese subjects.

Authors:  Takahisa Yamasaki; Tadayuki Oshima; Toshihiko Tomita; Takashi Kondo; Fumihiko Toyoshima; Jun Sakurai; Hirokazu Fukui; Takayuki Matsumoto; Jiro Watari; Hiroto Miwa
Journal:  J Gastroenterol       Date:  2012-09-25       Impact factor: 7.527

8.  Deletion of P2X3 receptors blunts gastro-oesophageal sensation in mice.

Authors:  S L McIlwrath; B M Davis; K Bielefeldt
Journal:  Neurogastroenterol Motil       Date:  2009-03-11       Impact factor: 3.598

9.  Lowered oesophageal sensory thresholds in patients with symptomatic but not excess gastro-oesophageal reflux: evidence for a spectrum of visceral sensitivity in GORD.

Authors:  K C Trimble; A Pryde; R C Heading
Journal:  Gut       Date:  1995-07       Impact factor: 23.059

10.  An orally active TRPV4 channel blocker prevents and resolves pulmonary edema induced by heart failure.

Authors:  Kevin S Thorneloe; Mui Cheung; Weike Bao; Hasan Alsaid; Stephen Lenhard; Ming-Yuan Jian; Melissa Costell; Kristeen Maniscalco-Hauk; John A Krawiec; Alan Olzinski; Earl Gordon; Irina Lozinskaya; Lou Elefante; Pu Qin; Daniel S Matasic; Chris James; James Tunstead; Brian Donovan; Lorena Kallal; Anna Waszkiewicz; Kalindi Vaidya; Elizabeth A Davenport; Jonathan Larkin; Mark Burgert; Linda N Casillas; Robert W Marquis; Guosen Ye; Hilary S Eidam; Krista B Goodman; John R Toomey; Theresa J Roethke; Beat M Jucker; Christine G Schnackenberg; Mary I Townsley; John J Lepore; Robert N Willette
Journal:  Sci Transl Med       Date:  2012-11-07       Impact factor: 17.956

View more
  6 in total

1.  Transient receptor potential vanilloid 4-dependent calcium influx and ATP release in mouse and rat gastric epithelia.

Authors:  Hiroshi Mihara; Nobuhiro Suzuki; Ammar Abdullkader Boudaka; Jibran Sualeh Muhammad; Makoto Tominaga; Yoshiaki Tabuchi; Toshiro Sugiyama
Journal:  World J Gastroenterol       Date:  2016-06-28       Impact factor: 5.742

Review 2.  Transient Receptor Potential Vanilloid 4 Regulation of Adenosine Triphosphate Release by the Adenosine Triphosphate Transporter Vesicular Nucleotide Transporter, a Novel Therapeutic Target for Gastrointestinal Baroreception and Chronic Inflammation.

Authors:  Hiroshi Mihara; Ammar Boudaka; Makoto Tominaga; Toshiro Sugiyama
Journal:  Digestion       Date:  2019-11-26       Impact factor: 3.216

Review 3.  Physiological and Pathological Significance of Esophageal TRP Channels: Special Focus on TRPV4 in Esophageal Epithelial Cells.

Authors:  Ammar Boudaka; Makoto Tominaga
Journal:  Int J Mol Sci       Date:  2022-04-20       Impact factor: 6.208

Review 4.  Progress on the Mechanism of Visceral Hypersensitivity in Nonerosive Reflux Disease.

Authors:  Cao Xu; Xiaoping Niu
Journal:  Gastroenterol Res Pract       Date:  2022-01-20       Impact factor: 2.260

5.  Identification of Unique Transcriptomic Signatures and Hub Genes Through RNA Sequencing and Integrated WGCNA and PPI Network Analysis in Nonerosive Reflux Disease.

Authors:  Ye Zhao; Teng Ma; Duowu Zou
Journal:  J Inflamm Res       Date:  2021-11-23

Review 6.  Effects of acids, pepsin, bile acids, and trypsin on laryngopharyngeal reflux diseases: physiopathology and therapeutic targets.

Authors:  Yading Li; Gaofan Xu; Bingduo Zhou; Yishuang Tang; Xiaowen Liu; Yue Wu; Yi Wang; Jing Kong; Tingting Xu; Cong He; Shengliang Zhu; Xiaosu Wang; Jianning Zhang
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-12-03       Impact factor: 3.236

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.